EPA, Companies Reach $2.1M Deal On OxyChem Site

POTTSTOWN PA – Current and former owners and operators of what once was an Occidental Chemical Corporation manufacturing plant on the southeast corner of Armand Hammer Boulevard and Industrial Highway in Lower Pottsgrove (PA) Township have agreed to pay $2.1 million for earlier cleanup efforts the site, the federal Environmental Protection Agency regional office in Philadelphia announced Wednesday (Jan. 25, 2012).

One of several entrances to the now-cleaned OxyChem site on Armand Hammer Boulevard, being marketed as the Tri-County Commerce Park

Under a consent decree filed in federal court by the Justice Department on behalf of EPA, the companies also assumed responsibility for all future cleanup costs. They include Occidental Chemical Corp., the most recent owner and often referred to as OxyChem; Glenn Springs Holdings Inc., an OxyChem subsidiary that has been managing the property’s clean-up and re-development; and Bridgestone Americas Tire Operations, which preceded OxyChem at the site with a tire manufacturing plant.

OxyChem manufactured polyvinyl chloride (PVC) plastic resins there from 1980 to 2005. It bought the property from the Firestone Tire and Rubber Company, now known as Bridgestone, which manufactured tires and PVC there from about 1945 to 1980.

From 1942 to 1985, operators used The site was used to dispose of industrial wastes including cutting oils, metal filings, tires, and PVC sludge resins. It was identified as having unsafe levels of trichloroethylene, vinyl chloride, and other hazardous substances in the soil and groundwater.

After OxyChem ended operations, the site was investigated during 1983 and later for potential pollutants. It was declared an EPA “Superfund” site to designate it as among the nation’s “most contaminated” locations, the agency announcement said. OxyChem, under EPA oversight, performed remedial action on the property and completed construction in 2008.

As of Thursday (Jan. 26), according to the EPA, the property was now considered safe for human exposure, and the migration of any contaminated ground water was deemed to be under control.

To encourage development along Armand Hammer Boulevard, which was renamed for OxyChem’s president, Lower Pottsgrove‘s Board of Commissioners had created a Local Economic Revitalization Tax Assistance Act (LERTA) district to give incoming business owners property tax breaks within the area. The district included the former OxyChem facility, the land now occupied by Aldi’s Supermarket and Home Depot, and other parcels stretching east to Sanatoga Station Road. The district’s authorization ended in 2008.

The property has since enjoyed a rebirth as a location for light- and moderate-industrial uses, and is being marketed as the Tri-County Commerce Park. A brochure about its tenants and available space can be downloaded here.

Other coverage:

Photo from CB Richard Ellis

Share

2 Responses to “EPA, Companies Reach $2.1M Deal On OxyChem Site”

Trackbacks/Pingbacks

  1. [...] EPA, Companies Reach $2.1M Deal On OxyChem Site A $2.1 million settlement to cover earlier clean-up costs at the Occidental Chemical manufacturing site on Armand Hammer Boulevard in Lower Pottsgrove has been reached between the Environmental Protection Agency and the property’s current and former owners. [...]

  2. [...] EPA, Companies Reach $2.1M Deal On OxyChem Site A $2.1 million settlement to cover earlier clean-up costs at the Occidental Chemical manufacturing site on Armand Hammer Boulevard in Lower Pottsgrove has been reached between the Environmental Protection Agency and the property’s current and former owners. [...]


From Our Sponsors

RSS Health News

  • Cervical cancer vaccines cut rates of HPV infections: U.S June 19, 2013
    CHICAGO (Reuters) - The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV - the sexually transmitted virus that causes the disease - by more than half among girls and young women, U.S. health officials said on Wednesday. […]
  • Niche drugmaker ViroPharma attracts takeover interest: sources June 19, 2013
    NEW YORK (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter. […]
  • New Hampshire nears approval of medical marijuana law June 19, 2013
    LITTLETON, New Hampshire (Reuters) - New Hampshire is set to become the final state in New England to allow medical marijuana after negotiators from the Republican-controlled Senate and Democratic-controlled House agreed Tuesday on a bill backed by Governor Maggie Hassan. […]
  • Hot flashes common even before menopause June 19, 2013
    NEW YORK (Reuters Health) - Most women expect hot flashes as a part of the "change of life," but more than half start sweating before menopause has actually begun, according to a survey. […]
  • EU fines Lundbeck and others 146 million euros for blocking rival drugs June 19, 2013
    BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals. […]
  • AstraZeneca, Bristol diabetes drug disappoints in key test June 19, 2013
    LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals. […]
  • Analysis: Hospital investors sold on U.S. health reform despite bumps June 19, 2013
    CHICAGO (Reuters) - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the gains of the broader stock market, as investors tallied up the benefits of President Barack Obama's healthcare reform. […]
  • Outbreak of deadly piglet virus spreads to 13 U.S. states June 19, 2013
    CHICAGO (Reuters) - A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed. […]
  • Call for overhaul of drug industry business model June 18, 2013
    LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says. […]
  • Enroll America sets private outreach for Obamacare sign-up June 18, 2013
    WASHINGTON (Reuters) - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months. […]

The Posts On Health At Twitter